Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Xin actin-binding repeat-containing protein 2 (XIRP2) is a cytoskeletal protein involved in the binding and protection of actin filaments from depolymerization[8][3]. XIRP2 is localized predominantly in striated muscle (including cardiac muscle), where it plays a critical scaffolding role in the formation and maturation of intercalated disks that connect cardiac myocytes and regulate their electrophysiological properties[6][8][4]. In the inner ear, XIRP2 is enriched in sensory hair cells, with specialized isoforms responsible for maintaining stereocilia structure, facilitating repair after mechanical damage, and preserving hearing function[1][2]. Deficiency or mutation of XIRP2 leads to pathology such as cardiac conduction defects, arrhythmias, cardiomyopathy, and hearing loss, and is suspected in certain neurodevelopmental disorders[3][1][4]. XIRP2 is not currently a therapeutic target for any approved drug, but genetic defects may have diagnostic value in specific diseases.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Xin actin-binding repeat-containing protein 2 (XIRP2).